Workflow
Chimin(603222)
icon
Search documents
济民健康8月21日龙虎榜数据
济民健康(603222)今日下跌3.88%,全天换手率28.82%,成交额16.80亿元,振幅14.90%。龙虎榜数据显 示,机构净卖出3424.91万元,营业部席位合计净买入1.27亿元。 融资融券数据显示,该股最新(8月20日)两融余额为2.52亿元,其中,融资余额为2.52亿元,融券余额 为1.07万元。近5日融资余额合计增加8990.30万元,增幅为55.58%。融券余额合计减少4.75万元,降幅 81.64%。 8月21日公司发布的半年报数据显示,上半年公司共实现营业收入3.66亿元,同比下降21.30%,实现净 利润-5269.59万元。(数据宝) 济民健康8月21日交易公开信息 | 买/ | 会员营业部名称 | 买入金额(万 | 卖出金额(万 | | --- | --- | --- | --- | | 卖 | | 元) | 元) | | 买一 | 东方证券股份有限公司杭州龙井路证券营业部 | 12514.98 | | | 买二 | 东吴证券股份有限公司苏州相城大道证券营业部 | 8069.77 | | | 买三 | 国泰海通证券股份有限公司三亚迎宾路证券营业部 | 4573.87 | | | 买 ...
“五连板”后突然大跌!牛股业绩“爆雷”:80后女高管私刻“萝卜章” 公司背上官司还亏大钱
Mei Ri Jing Ji Xin Wen· 2025-08-21 10:41
8月20日晚间,"五连板"牛股济民健康(603222.SH)发布2025年半年报,报告显示公司营收大幅下滑, 净利润由盈转亏,经营活动产生的现金流量同比转负。 同日晚间,济民健康再度发布股票异动公告,公司股票自2025年8月13日至8月19日收盘价格累计涨幅达 53.78%,并连续两次触及异动。8月20日,公司股票再次涨停,换手率达到31.31%,远高于行业同期平 均水平。 8月21日,济民健康股价大跌,一度跌停,尾盘跌幅收窄至近4%。 业绩下滑,由盈转亏 济民健康半年报显示,报告期内公司实现营收3.66亿元,同比下降21.30%;归母净利润-5269.59万元, 上年同期为2544.5万元;扣非净利润-5320万元,上年同期2440万元,均同比转亏。 | | 本报告期末 | 上年度末 | 本报告期末比上年度末 增减(%) | | | --- | --- | --- | --- | --- | | 总资产 | 2,527.902,067.09 | 2.414.387.293.72 | | 4.70 | | 归属于上市公司股东的 净资产 | 1,423,926,583.03 | 1,480,824,869.60 ...
“五连板”后突然大跌!牛股业绩“爆雷”:80后女高管私刻“萝卜章”,公司背上官司还亏大钱
Mei Ri Jing Ji Xin Wen· 2025-08-21 10:21
8月20日晚间,"五连板"牛股济民健康(603222)(603222.SH)发布2025年半年报,报告显示公司营收大幅下滑,净利润由盈转亏,经营 活动产生的现金流量同比转负。 同日晚间,济民健康再度发布股票异动公告,公司股票自2025年8月13日至8月19日收盘价格累计涨幅达53.78%,并连续两次触及异 动。8月20日,公司股票再次涨停,换手率达到31.31%,远高于行业同期平均水平。 8月21日,济民健康股价大跌,一度跌停,尾盘跌幅收窄至近4%。 | | 本报告期末 | 上年度末 | 本报告期末比上年度末 | | | --- | --- | --- | --- | --- | | | | | 增减(%) | | | 总资产 | 2.527.902.067.09 | 2.414.387.293.72 | | 4.70 | | 归属于上市公司股东的 净资产 | 1,423,926,583.03 | 1,480,824,869.60 | | -3.84 | | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | | | | | 减(%) | | | 营业收入 | 366.449.449.00 | 46 ...
A股突变,券商股集体走低
Zheng Quan Shi Bao· 2025-08-21 07:12
Market Overview - The A-share market experienced a sudden decline in the afternoon, with the Shanghai Composite Index dropping over 0.2% before recovering slightly, while the Shenzhen Component and ChiNext indices fell [2] - The trading volume in the Shanghai and Shenzhen markets exceeded 2 trillion yuan for the first time this year, marking the seventh consecutive trading day of such volume [2] Sector Performance - Securities stocks collectively faced a pullback, with notable declines including Changcheng Securities down over 6% and Hato Securities down over 5% [2][3] - Several high-priced stocks hit the daily limit down, including Lianhuan Pharmaceutical and Zhongdian Xindong, with others like Shunlian Bio and Sainuo Medical dropping over 8% [4] Banking Sector - In contrast, bank stocks showed strength in the afternoon, with Agricultural Bank of China and Postal Savings Bank reaching new historical highs during the session [2] Hong Kong Market - The Hang Seng Index fell over 0.5%, and the Hang Seng Tech Index dropped more than 1% [6] - AAC Technologies Holdings (02018.HK) saw a rapid decline of over 14% following the release of its interim results, despite reporting a revenue of 13.32 billion yuan, a year-on-year increase of 18.4% [6][8] Company Performance - AAC Technologies reported a gross margin of 20.7%, down 0.8 percentage points year-on-year, attributed to changes in product mix, while net profit attributable to shareholders increased by 63.1% to 876 million yuan due to improved profitability in optical business and rapid growth in precision structural components [8] - CICC noted that the overall valuation level of A-shares remains reasonable, but the rapid increase in trading volume may lead to short-term volatility [8]
A股高位股持续下挫,联环药业、中电鑫龙、飞龙股份、金田股份跌停,申联生物、赛诺医疗、济民健康、卧龙电驱、川润股份、汉钟精机、广生堂等均跌超8%
Ge Long Hui· 2025-08-21 06:03
【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱: news_center@staff.hexun.com 格隆汇8月21日|A股市场午后高位股持续下挫,联环药业、中电鑫龙、飞龙股份、金田股份跌停,申 联生物、赛诺医疗、济民健康、卧龙电驱、川润股份、汉钟精机、广生堂等均跌超8%。 (责任编辑:宋政 HN002) ...
高位股下挫,联环药业等多股跌停
Ge Long Hui A P P· 2025-08-21 05:54
格隆汇8月21日|A股市场午后高位股持续下挫,联环药业、中电鑫龙、飞龙股份、金田股份跌停,申 联生物、赛诺医疗、济民健康(维权)、卧龙电驱、川润股份、汉钟精机、广生堂等均跌超8%。 MACD金叉信号形成,这些股涨势不错! ...
济民健康:上半年营收利润双降 陷何清红私刻印章风波
南方财经8月21日电,济民健康(603222.SH)近日发布2025年半年度报告,公司实现营收3.66亿元,同 比下滑21.30%;归属于上市公司股东的净利润亏损5269.59万元,同比骤降307.10%,扣非后净利润同样 亏损5320.10万元。业绩亏损主因多重利空叠加:安全注射器外销收入降39.58%;"何清红私刻印章事 件"冲击更大,其冒用公司名义与39家经销商签订兜底协议,导致公司预充式导管冲洗器等内销收入下 滑92.24%,涉案金额达1.18亿元,公司还因此对相关库存计提跌价准备约2000万元。此外,经营活动现 金流净额为-3609.62万元,因收入下降及诉讼冻结资金导致现金流出增加。双重打击下,公司短期借款 飙升至4.09亿元,占总资产16.19%。 ...
高开低走,济民健康盘中跌逾8%
Bei Jing Shang Bao· 2025-08-21 02:03
交易行情显示,8月21日,济民健康高开0.84%,开盘价为11.96元/股,截至北京商报记者发稿,济民健 康报11元/股,跌幅为7.25%。 值得一提的是,济民健康于8月14日—20日连续五个交易日涨停。8月20日晚间,济民健康披露2025年半 年报显示,公司上半年营业收入3.66亿元,同比下降21.3%。归属净利润为-5269.59万元,同比由盈转 亏。 北京商报讯(记者 丁宁)8月21日,此前斩获五连板的济民健康(603222)高开低走,盘中一度跌逾 8%。 ...
7月批准注册医械产品295个;适龄女生可免费接种HPV疫苗
Policy Developments - The National Healthcare Security Administration issued the "Guidelines for the Establishment of Pricing Projects for Physical Therapy Medical Services (Trial)" which integrates existing pricing projects into 32 items, with 7 additional charges and 1 expansion item [2] Medical Device Approvals - In July, the National Medical Products Administration approved 295 medical device products, including 240 domestic Class III devices, 21 imported Class III devices, 29 imported Class II devices, and 5 devices from Hong Kong, Macau, and Taiwan [4] Company Announcements - New Industries announced that 18 of its chemiluminescent reagent products received IVDR CE certification, allowing them to enter the EU market, which is expected to enhance the company's competitiveness [5] - Jining Pharmaceutical received a drug re-registration approval for hydrolyzed protein injection, which is used for severe amino acid deficiency and will help restore normal production and sales [6] - Chongqing Pharmaceutical Holdings reported a net profit of 282 million yuan for the first half of the year, with a revenue of 41.188 billion yuan, marking a 3.54% year-on-year increase [8] - Jimin Health reported a net loss of 52.6959 million yuan for the first half of 2025, with a revenue of 36.6 million yuan, down 21.30% year-on-year [9] - Chenguang Bio announced plans to transfer 97.5% of its subsidiary Chenguang Tianrun Pharmaceutical to Sichuan Tongsheng Biomedical, with the transfer based on the subsidiary's equity as of July 31, 2025 [11] - Baiyang Pharmaceutical's controlling shareholder plans to increase capital and change the shareholding structure, with a new entity set to acquire 80% of the controlling group [13] Industry Events - A groundbreaking cervical spine surgery was successfully performed in Shanghai, utilizing innovative "satellite steel plate" technology to stabilize a severely injured patient's spine [15] - Guangxi plans to provide free HPV vaccinations to nearly 960,000 eligible girls from 2025 to 2027, emphasizing the importance of preventive healthcare [16] Shareholder Actions - Multiple shareholders of Sanxin Medical plan to reduce their stakes in the company due to personal financial needs, with specific share amounts outlined for each individual [18]
【早报】育儿补贴,免征个税;港交所将研究24小时交易机制
财联社· 2025-08-20 23:09
Industry News - The National Financial Supervision Administration is seeking public opinion on the draft of the "Commercial Bank Merger Loan Management Measures," which states that merger loans can only be used for high-industry relevance or strategic synergy mergers, and the controlling merger loan proportion cannot exceed 70% of the transaction price [4] - A research team from the Institute of Metal Research of the Chinese Academy of Sciences has made a significant breakthrough by observing the "full temperature pressure card effect" in a material called potassium hexafluorophosphate (KPF6), which can achieve cooling effects across a wide temperature range [4] - The Hong Kong Stock Exchange's CEO announced that they will study the implementation of a 24-hour trading mechanism, following Nasdaq's plan to implement it in the second half of 2026 [4] Company News - Weicet Technology reported a net profit increase of 831% year-on-year in the first half of the year [8] - Heng Rui Pharmaceutical announced a net profit increase of 29.67% year-on-year in the first half of the year and plans to repurchase A-shares worth no less than 1 billion and no more than 2 billion yuan for employee stock ownership plans [8] - Muyuan Foods reported a staggering net profit increase of 1170% year-on-year in the first half of the year [9] - Tianwei Foods is planning to issue H-shares and list on the Hong Kong Stock Exchange [10] - Yunnan Zhiyie announced that there are currently no specific plans for large-scale production of 6-inch indium phosphide chips [10] - ByteDance denied rumors of collaboration with Chip Original Co. on AI chip design [10]